Inhibition of antiplasmin, and effect of protease I in patients with leukaemia.
D000328:Adult; D000368:Aged; D001230:Aspergillus; D005260:Female; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D007938:Leukemia / Q000097:blood*; D007945:Leukemia, Lymphoid / Q000097:blood / Q000188:drug therapy; D007948:Leukemia, Monocytic, Acute / Q000097:blood / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy; D007958:Leukocyte Count; D008297:Male; D010447:Peptide Hydrolases / Q000494:pharmacology* / Q000627:therapeutic use
D010447:Peptide Hydrolases; D005341:Fibrinolysin